Compare FOLD & PTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOLD | PTRN |
|---|---|---|
| Founded | 2002 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.0B |
| IPO Year | 2007 | 2025 |
| Metric | FOLD | PTRN |
|---|---|---|
| Price | $14.19 | $11.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $29.79 | $19.89 |
| AVG Volume (30 Days) | ★ 14.8M | 866.6K |
| Earning Date | 11-04-2025 | 02-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $598,704,000.00 | ★ $2,293,676,000.00 |
| Revenue This Year | $21.49 | $39.02 |
| Revenue Next Year | $18.25 | $24.87 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 21.28 | ★ 67.86 |
| 52 Week Low | $5.51 | $11.40 |
| 52 Week High | $14.36 | $20.10 |
| Indicator | FOLD | PTRN |
|---|---|---|
| Relative Strength Index (RSI) | 91.10 | N/A |
| Support Level | $10.64 | N/A |
| Resistance Level | $11.14 | N/A |
| Average True Range (ATR) | 0.36 | 0.00 |
| MACD | 0.28 | 0.00 |
| Stochastic Oscillator | 96.46 | 0.00 |
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
Pattern Group Inc is an ecommerce accelerator, uses its technology platform, data science and a team of experts to drive growth for brands. The Company acquires inventory from brand partners to sell to consumers, enabling full control over content, pricing, logistics and customer service. Brand partners that contract with the Company operate in various industries including health and wellness, beauty and personal care, home and lifestyle, pet, sports and outdoors and consumer electronics.